# 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer

> **NCT02488070** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 10 (actual)

## Conditions studied

- Recurrent Prostate Carcinoma

## Interventions

- **PROCEDURE:** Computed Tomography
- **DRUG:** Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx)
- **PROCEDURE:** Magnetic Resonance Imaging
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT02488070
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-08
- **Final completion:** 2016-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02488070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02488070, "68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02488070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*